Bristol Myers Capital Expenditure — Historical Data
Bristol Myers (BMY) capital expenditure was $1.3B in FY2025 (+5% YoY). The tables below show the complete quarterly and annual capital expenditure history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Capital Expenditure
Fiscal Year
Capital Expenditure
YoY
2025
$1.3B
+5%
2024
$1.2B
+3%
2023
$1.2B
+8%
2022
$1.1B
-12%
2021
$1.3B
+69%
2020
$753M
-10%
2019
$836M
-12%
2018
$951M
-10%
2017
$1.1B
-13%
2016
$1.2B
+48%
2015
$820M
+56%
2014
$526M
-2%
2013
$537M
-2%
2012
$548M
+49%
2011
$367M
-13%
2010
$424M
-42%
2009
$730M
-22%
2008
$941M
+12%
2007
$843M
Recent Quarterly Capital Expenditure
Quarter
Capital Expenditure
Q2 2026
$305M
Q1 2026
$347M
Q4 2025
$370M
Q3 2025
$320M
Q2 2025
$361M
Q1 2025
$260M
Q4 2024
$378M
Q3 2024
$324M
Q2 2024
$262M
Q1 2024
$284M
Q4 2023
$330M
Q3 2023
$342M
Source: BMY on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.